[Federal Register Volume 75, Number 144 (Wednesday, July 28, 2010)]
[Notices]
[Page 44274]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-18498]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Nanotechnology Imaging and Sensing Platforms for Improved
Diagnosis of Cancer.
Date: August 31, 2010.
Time: 12 p.m. to 1:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 210, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Kenneth L. Bielat, PhD, Scientific Review
Officer, Special Review Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 7147, Bethesda, MD 20892-8329, 301-496-7576,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel, Basic, Translational and Clinical Oncology.
Date: September 28-29, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel & Executive Meeting Ctr. Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: David G. Ransom, PhD, Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 6116 Executive Blvd, Rm 8133,
Bethesda, MD 20892-8328, 301-451-4757, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel, Drug Discovery, Biomarkers, Therapeutics.
Date: September 28-29, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter J. Wirth, PhD, Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, 6116 Executive Boulevard, Room 8129,
Bethesda, MD 20892-8328, 301-496-7565, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: July 22, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-18498 Filed 7-27-10; 8:45 am]
BILLING CODE 4140-01-P